<DOC>
	<DOCNO>NCT02628028</DOCNO>
	<brief_summary>The main purpose study evaluate safety effectiveness LY3337641 adult rheumatoid arthritis ( RA ) .</brief_summary>
	<brief_title>A Study LY3337641 Rheumatoid Arthritis</brief_title>
	<detailed_description />
	<mesh_term>Arthritis</mesh_term>
	<mesh_term>Arthritis , Rheumatoid</mesh_term>
	<criteria>Female subject test negative pregnancy screen agree breastfeed Female subject : agree use reliable method birth control start screen 2 week last dose study drug nonchildbearing potential Male subject : agree use reliable method birth control start screen 2 week last dose study drug undergone vasectomy Have diagnosis RA base 2010 ACR/European League Rheumatism criterion Have least 1 follow : rheumatoid factor anticitrullinated peptide antibody ( ACPA ) screening OR radiograph document bony erosion Have active RA , define : Part A : ≥3 swollen joint ( base 66joint count ) Part B : ≥6 swollen joint ( base 66joint count ) ≥6 tender joint ( base 68joint count ) hsCRP level great upper limit normal ( ULN ) OR positive ACPA Part B : Have inadequate response , loss response , intolerance least 1 synthetic OR biologic diseasemodifying antirheumatic drug ( DMARD ) Have receive following : Part B : prior treatment product directly target Bruton 's tyrosine kinase ( BTK ) ( market investigational ) belimumab , natalizumab , vedolizumab within 6 month prior baseline Bcelldepleting agent ( rituximab ) celldepleting biologics ( eg , antiCD3 antibody ) within 12 month prior screen Part A time prior screen Part B Have know hypogammaglobulinemia Have hepatitis C virus , hepatitis B virus human immunodeficiency virus Have active tuberculosis ( TB ) Are high risk infection recent evidence clinically significant infection Have lymphoma , leukemia , malignancy within previous 5 year except treat basal cell squamous epithelial carcinoma skin Have receive live ( attenuate ) vaccine within 28 day prior baseline plan receive one study</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>April 2017</verification_date>
</DOC>